









Mercado
/
Acciones
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

4.990USD

-0.180-3.48%

Cierre 11/06, 16:00（ET）Cotizaciones retrasadas 15 min

193.98MCap. mercado

PérdidaP/E TTM



Quanterix Corp

4.990

-0.180-3.48%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Quanterix Corp Compañía

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Información de Quanterix Corp



Símbolo de cotizaciónQTRX

Nombre de la empresaQuanterix Corp

Fecha de salida a bolsaDec 07, 2017

Director ejecutivoDr. Masoud Toloue, Ph.D.

Número de empleados471

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 07

Dirección900 Middlesex Turnpike

CiudadBILLERICA

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal01821

Teléfono16173019400

Sitio Webhttps://www.quanterix.com/

Símbolo de cotizaciónQTRX

Fecha de salida a bolsaDec 07, 2017

Director ejecutivoDr. Masoud Toloue, Ph.D.

Ejecutivos de Quanterix Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.14%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

287.11K

-0.52%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

138.14K

+3.81%

Ms. Karen A. Flynn

Independent Director

26.41K

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

15.07K

-1.50%

Mr. Scott Mendel

Director

6.27K

+49.75%

Dr. Myla P. Lai-Goldman, M.D.

Director

5.02K

+70.88%

Mr. Jeffrey Thomas (Jeff) Elliott

Independent Director

3.96K

-79.63%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Mr. Paul M. Meister

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.14%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

287.11K

-0.52%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

138.14K

+3.81%

Ms. Karen A. Flynn

Independent Director

26.41K

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

15.07K

-1.50%

Mr. Scott Mendel

Director

6.27K

+49.75%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Product revenue

16.83M

68.83%

Service and other revenue

7.09M

28.99%

Collaboration and license revenue

532.00K

2.18%

Por regiónUSD

Nombre

Ganancia

Proporción

North America

14.67M

60.01%

EMEA

6.51M

26.61%

Asia Pacific

3.27M

13.38%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Product revenue

16.83M

68.83%

Service and other revenue

7.09M

28.99%

Collaboration and license revenue

532.00K

2.18%

Estadísticas de accionistas

Actualizado: sáb., 1 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

Portolan Capital Management, L.L.C.

7.82%

Columbia Threadneedle Investments (UK)

6.73%

BlackRock Institutional Trust Company, N.A.

5.70%

The Vanguard Group, Inc.

5.44%

Kent Lake PR LLC

4.50%

Otro

69.81%

Accionistas

Proporción

Portolan Capital Management, L.L.C.

7.82%

Columbia Threadneedle Investments (UK)

6.73%

BlackRock Institutional Trust Company, N.A.

5.70%

The Vanguard Group, Inc.

5.44%

Kent Lake PR LLC

4.50%

Otro

69.81%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

34.76%

Investment Advisor

19.39%

Hedge Fund

13.18%

Individual Investor

5.88%

Research Firm

3.94%

Pension Fund

0.67%

Bank and Trust

0.27%

Family Office

0.13%

Venture Capital

0.12%

Otro

21.65%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

383

33.64M

72.39%

-10.02M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Portolan Capital Management, L.L.C.

3.63M

7.82%

+670.23K

+22.62%

Jun 30, 2025

Columbia Threadneedle Investments (UK)

3.13M

6.73%

+128.33K

+4.28%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.65M

5.7%

-36.11K

-1.35%

Jun 30, 2025

The Vanguard Group, Inc.

2.53M

5.44%

+3.27K

+0.13%

Jun 30, 2025

Kent Lake PR LLC

2.09M

4.5%

-211.50K

-9.19%

Jul 14, 2025

Walt (David R)

1.86M

4.01%

+2.15K

+0.12%

Jul 31, 2025

Invenomic Capital Management LP

1.14M

2.46%

+242.86K

+26.92%

Jun 30, 2025

William Blair Investment Management, LLC

1.13M

2.43%

+21.92K

+1.98%

Jun 30, 2025

Columbia Threadneedle Investments (US)

1.11M

2.39%

+393.31K

+54.91%

Jun 30, 2025

Easterly Investment Partners LLC

1.08M

2.33%

-241.99K

-18.25%

Jun 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

Invesco NASDAQ Future Gen 200 ETF

0.58%

iShares Micro-Cap ETF

0.04%

Fidelity Enhanced Small Cap ETF

0.03%

Avantis US Small Cap Equity ETF

0.02%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

iShares Biotechnology ETF

0.02%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.58%

iShares Micro-Cap ETF

Proporción0.04%

Fidelity Enhanced Small Cap ETF

Proporción0.03%

Avantis US Small Cap Equity ETF

Proporción0.02%

Invesco RAFI US 1500 Small-Mid ETF

Proporción0.02%

iShares Biotechnology ETF

Proporción0.02%

Proshares Ultra Russell 2000

Proporción0.01%

ProShares UltraPro Russell2000

Proporción0.01%

iShares Russell 2000 Value ETF

Proporción0.01%

Global X Russell 2000 ETF

Proporción0.01%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

